Novel features in the evolution of adenylosuccinate lyase deficiency

详细信息	查看全文 | 推荐本文 |

• 作者：Belé ; n Pé ; rez-Dueñ ; as^a ; ^c ; ^{bperez@hsjdbcn.org} ; Á ; ngela Sempere^a ; Jaume Campistol^a ; ^c ; Itziar Alonso-Colmenero^a ; Marí ; a Dí ; ez^a ; Ver&oacute ; nica Gonzá ; lez^a ; Begoñ ; a Merinero^c ; ^d ; Lourdes R. Desviat^c ; ^d ; Rafael Artuch^b ; ^c
• 关键词：Adenylosuccinate lyase deficiency ; Autism spectrum disorder ; d-ribose ; Reflex seizures ; Status epilepticus ; Stereotypies
• 刊名：European Journal of Paediatric Neurology
• 出版年：2012
• 期刊代码：120_10903798
• 类别：med
• 出版时间：July, 2012
• 卷：16
• 期：4
• 页码：343-348
• 文件大小：730 K

摘要

Background

Adenylosuccinate lyase (ADSL) deficiency is an autosomal recessive disorder of the purine synthesis which results in accumulation of succinylpurines (succinyladenosine (S-Ado) and succinylamino-imidazole carboxamide riboside (SAICAr)) in body fluids. Patients present developmental delay, often accompanied by epilepsy and autistic spectrum disorders.

Objectives

To describe atypical neurological features in the evolution of three novel unrelated cases of ADSL deficiency.

Patients

A 9-year-old boy with severe cognitive impairment and autistic behaviour received d-ribose therapy for one year. Drug withdrawal was associated with acute neurological deterioration, severe brain atrophy and demyelination on MRI. The second patient is a 5.5-year-old girl with mild developmental delay who presented a benign course with moderate cognitive impairment as the only feature in her evolution. The final patient is a 14-year-old boy with severe cognitive impairment who developed drug-resistant epilepsy and bathing reflex seizures, progressive spasticity in the lower limbs and thoracic deformity.

Methods

SAICAr and S-Ado in urine were analysed by HPLC with diode array detection. Diagnosis was confirmed by molecular analysis of the ADSL gene.

Results

An elevation of S-Ado and SAICAr excretion in urine was detected in all three patients. The patients were homozygous for the missence change p.I369L and for the novel change p.M389V.

Conclusion

Drug-resistant epilepsy and specific therapeutic interventions may modify the neurological outcome in ADSL deficiency. d-ribose must be considered with caution as, in our experience, it returns no clinical benefit and drug withdrawal can precipitate status epilepticus and acute neurological deterioration.